The latest news from The Hyve on Open Source solutions for bioinformatics

Sjoerd van Hagen

Sjoerd van Hagen

Sjoerd is a highly adaptive and versatile software architect and developer who has a strong theoretical background in algorithms and takes pride in writing clean, maintainable code. His love for startups has brought him in contact with a wide variety of technologies, ranging from concurrent programming, cloud systems and big data to building (web)frontends. He also likes teaching and sharing knowledge and will not shy away from a good discussion. Activities outside the area of computer science include learning stuff, playing guitar, running, cycling, hiking and teasing his cat. His musical taste takes him anywhere from classical to progressive rock and from a little jazz and blues to metal.

Recent Posts

Using treatment response data to find targeted therapies in cBioPortal

October 11, 2019 | By Sjoerd van Hagen 0
The Hyve has implemented treatment support data support in cBioPortal, which has been included in the recently released 3.1.0 version of the platform. This will allow researchers to correlate drug response with genetic alterations, helping them in[…]
[ Read more ]

Rich metadata in cBioPortal: a step towards FAIRness

June 04, 2019 | By Sjoerd van Hagen 0
The cBioPortal community and The Hyve have always championed Open Source and Open Data. Now that the FAIR principles for data stewardship are gaining momentum, we cannot stay behind! To take a small step towards FAIR compliance, rich metadata[…]
[ Read more ]

Kick-starting Open Targets with The Hyve

February 18, 2019 | By Sjoerd van Hagen 0
2018 was a great year for The Hyve, in which we set the first steps in supporting Open Targets. The Open Targets Platform was already on our radar as an interesting platform, Open Source, user-friendly and good-looking, the kind of platform we love[…]
[ Read more ]

Adding your own annotations to mutations in cBioPortal

February 09, 2018 | By Sjoerd van Hagen 0
One of the key challenges in cancer research is to find patients that will respond well to targeted drug therapy. Specific mutations in a patient’s tumor can be an indication of the patient’s potential responsiveness to such therapy.
[ Read more ]

Integrated GSVA Visualisation in cBioPortal

July 21, 2017 | By Sjoerd van Hagen 0
[ Read more ]

MatchMiner: Fishing in the sea of clinical trials

April 02, 2017 | By Sjoerd van Hagen 0
The world of clinical trials can be overwhelming. More and more clinical trials are conducted, and each of them is getting more complex. Multi-arm trials have several advantages over traditional two arm trials. Testing multiple treatments at once:
[ Read more ]

GWAS functionality ported to Postgres in MATURA project

March 21, 2016 | By Sjoerd van Hagen 0
In the MRC MATURA project The Hyve has been working with Queen Mary University London to enable GWAS analysis within tranSMART for Postgres, sponsored by Janssen.  As detailed below, we have ported the GWAS functionality in Oracle to Postgres, set[…]
[ Read more ]

IMI/eTriks alignment workshop

June 10, 2015 | By Sjoerd van Hagen 0
During the TranSMART architectural workshop we have discussed the future of TranSMART from a developer perspective. We focussed on creating a solid but flexible, maintainable architecture on which we can build new features without losing too much[…]
[ Read more ]

TransLocation: LSP-TranSMART workshop in Copenhagen

May 28, 2015 | By Sjoerd van Hagen 0
On a nice spring evening Tim and I flew to Copenhagen to meet up with the people of Gritsystems. Together we form the technical heart of the implementation team of the ND4BB InfoCenter (a repository for preclinical and clinical data to facilitate[…]
[ Read more ]

Outcomes of the TranSMART Molgenis workshop

April 10, 2015 | By Sjoerd van Hagen 0
The Hyve has active collaborations with several academic groups in The Netherlands. On 24 and 25 March, we organized a joint workshop with the Molgenis team from UMC Groningen (led by Morris Swertz). We collaborate with Molgenis, amongst others, in[…]
[ Read more ]